StockNews.com Upgrades Aspen Aerogels (NYSE:ASPN) to Sell

Aspen Aerogels (NYSE:ASPN) was upgraded by equities research analysts at StockNews.com to a “sell” rating in a report issued on Wednesday.

Other equities analysts have also recently issued research reports about the stock. Piper Sandler reduced their price target on shares of Aspen Aerogels from $36.00 to $33.00 and set an “overweight” rating on the stock in a research report on Tuesday, October 22nd. Craig Hallum decreased their target price on Aspen Aerogels from $21.00 to $18.00 and set a “buy” rating for the company in a research report on Friday, February 14th. Barclays dropped their price target on Aspen Aerogels from $27.00 to $25.00 and set an “overweight” rating on the stock in a research report on Tuesday, November 12th. Canaccord Genuity Group decreased their price objective on Aspen Aerogels from $20.00 to $15.00 and set a “buy” rating for the company in a report on Friday, February 14th. Finally, Seaport Res Ptn lowered Aspen Aerogels from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, February 12th. One equities research analyst has rated the stock with a sell rating, one has given a hold rating and nine have assigned a buy rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average price target of $22.44.

Aspen Aerogels Price Performance

Shares of ASPN stock opened at $8.14 on Wednesday. The company has a debt-to-equity ratio of 0.27, a quick ratio of 2.48 and a current ratio of 2.93. Aspen Aerogels has a fifty-two week low of $8.02 and a fifty-two week high of $33.15. The firm has a market cap of $667.48 million, a P/E ratio of 50.85 and a beta of 2.14. The business’s 50 day moving average price is $11.85 and its 200-day moving average price is $18.22.

Aspen Aerogels (NYSE:ASPN) last released its quarterly earnings results on Wednesday, February 12th. The construction company reported $0.15 earnings per share for the quarter, beating the consensus estimate of $0.04 by $0.11. Aspen Aerogels had a net margin of 2.95% and a return on equity of 7.49%. On average, equities research analysts anticipate that Aspen Aerogels will post 0.22 earnings per share for the current year.

Hedge Funds Weigh In On Aspen Aerogels

Institutional investors and hedge funds have recently modified their holdings of the stock. Millennium Management LLC boosted its stake in Aspen Aerogels by 4,757.8% in the 4th quarter. Millennium Management LLC now owns 1,622,022 shares of the construction company’s stock worth $19,270,000 after purchasing an additional 1,588,632 shares in the last quarter. Point72 Asset Management L.P. purchased a new position in Aspen Aerogels in the fourth quarter worth about $13,122,000. Alyeska Investment Group L.P. bought a new position in shares of Aspen Aerogels in the fourth quarter worth approximately $9,504,000. Dendur Capital LP purchased a new stake in shares of Aspen Aerogels during the fourth quarter valued at approximately $9,207,000. Finally, FMR LLC grew its holdings in shares of Aspen Aerogels by 23.6% during the third quarter. FMR LLC now owns 4,050,896 shares of the construction company’s stock valued at $112,169,000 after buying an additional 773,647 shares during the last quarter. 97.64% of the stock is currently owned by institutional investors.

Aspen Aerogels Company Profile

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.